Anhui Fengyuan Pharmaceutical Co., Ltd. (000153.SZ)

CNY 6.42

(0.78%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 4.39 Billion 4.46 Billion 3.81 Billion 3.63 Billion 3.55 Billion 3 Billion
Total Current Assets 1.9 Billion 2.07 Billion 1.69 Billion 1.73 Billion 1.73 Billion 1.58 Billion
Cash And Short Term Investments 319.9 Million 353.13 Million 251.3 Million 282.32 Million 360.59 Million 311.38 Million
Cash and Cash Equivalents 319.9 Million 353.13 Million 251.3 Million 275.33 Million 350.72 Million 303.59 Million
Short Term Investments -213.36 Million 80.68 Million -226.93 Million 6.98 Million 9.87 Million 7.79 Million
Net Receivables 984.77 Million 925.89 Million 839.17 Million 887.85 Million 864.71 Million 811.46 Million
Inventory 573.57 Million 699.14 Million 569.53 Million 527.15 Million 486.8 Million 460.99 Million
Other Current Assets 24.65 Million 99.22 Million 34.76 Million 40.96 Million 27.08 Million 4.31 Million
Total Non-Current Assets 2.48 Billion 2.39 Billion 2.12 Billion 1.89 Billion 1.82 Billion 1.41 Billion
Net PPE 1.51 Billion 1.46 Billion 1.22 Billion 1.04 Billion 877.11 Million 806.55 Million
Good Will And Intangible Assets 293.54 Million 252.78 Million 233.71 Million 220.26 Million 182.82 Million 177.96 Million
Good Will 7.91 Million 7.91 Million 7.91 Million 11.51 Million 11.51 Million 11.51 Million
Intangible Assets 285.62 Million 244.86 Million 225.79 Million 208.75 Million 171.31 Million 166.45 Million
Long-Term Investments 575.8 Million 566.76 Million 556.44 Million 312.67 Million 423.12 Million 212.46 Million
Tax Assets 60.23 Million 39.97 Million 37.45 Million 21 Million 21.57 Million 18.01 Million
Other Non Current Assets 44.96 Million 70.63 Million 70.4 Million 299.9 Million 315.76 Million 204.83 Million
Other Assets 1.00 - 1.00 - 1.00 -
Total Liabilities 2.47 Billion 2.71 Billion 2.25 Billion 2.18 Billion 2.23 Billion 1.71 Billion
Total Current Liabilities 2.01 Billion 2.34 Billion 1.92 Billion 2.06 Billion 2.03 Billion 1.63 Billion
Account Payables 746.1 Million 722.74 Million 612.93 Million 712.29 Million 962.26 Million 781.54 Million
Tax Payables 49.9 Million 68.07 Million 43.46 Million 45.44 Million 40.49 Million 36.54 Million
Short Term Debt 492.79 Million 598.39 Million 501.07 Million 582.58 Million 492.76 Million 367.17 Million
Deferred Revenue 764.53 Million 257.21 Million 790.51 Million 756.68 Million 514.98 Million 36.54 Million
Other Current Liabilities 10.19 Million 766.28 Million 15.89 Million 13.62 Million 64.69 Million 454.69 Million
Total Non Current Liabilities 458.85 Million 369.83 Million 338.21 Million 123.05 Million 197.78 Million 76.24 Million
Long-Term Debt 194.96 Million 189.56 Million 114.04 Million 27.03 Million 105.11 Million -
Deferred Revenue Non Current 238.04 Million 151.92 Million 150.88 Million 77.26 Million 78.9 Million 58.96 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.00 - 50.62 Million 1.00 1.00 1.00
Other Liabilities 0.00 - 1.00 1.00 - -
Total Equity 1.91 Billion 1.75 Billion 1.55 Billion 1.44 Billion 1.32 Billion 1.29 Billion
Stock Holders Equity 1.88 Billion 1.72 Billion 1.52 Billion 1.41 Billion 1.32 Billion 1.28 Billion
Common Stock 332.02 Million 332.11 Million 312.14 Million 312.14 Million 312.14 Million 317.07 Million
Retained Earnings 888.73 Million 764.35 Million 629.25 Million 518.89 Million 417.19 Million 370.24 Million
Accumulated other comprehensive income 53.1 Million 595.18 Million 112.2 Million 107.9 Million 120.43 Million 100.46 Million
Common Stock Equity 1.88 Billion 1.72 Billion 1.52 Billion 1.41 Billion 1.32 Billion 1.28 Billion
Capital Lease Obligation 20.21 Million 20.71 Million 28.04 Million 38.26 Million - -
Total Investments 362.44 Million 371.45 Million 329.51 Million 319.65 Million 433 Million 220.25 Million
Total Debt 687.76 Million 787.95 Million 615.11 Million 609.62 Million 597.87 Million 367.17 Million
Net Debt 367.85 Million 434.82 Million 363.81 Million 334.28 Million 247.15 Million 63.58 Million

Balance Sheet Charts